RxDoctor Payments Data

Hien Nguyen, DO

Family Medicine · Garden Grove, CANPI 1902335904

Payments from drug & device makers

$501in general payments, 2019–2025

Across 22 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$83
  • Abbott$76
  • Novo Nordisk$72
  • Pfizer$58
  • Lilly USA, LLC$52
  • Boehringer Ingelheim$36
  • plus $125 from 6 others

What the payments were for

  • Food & beverage$501100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$501 in reported general payments places this provider in the 60th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$27,184
Medicare patients
86
Services billed
275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol46$47,010
EliquisApixaban30$32,800
OzempicSemaglutide26$32,236
JanuviaSitagliptin Phosphate20$29,936
JardianceEmpagliflozin14$15,273
XareltoRivaroxaban12$12,413
Synjardy XrEmpagliflozin/Metformin Hcl11$10,640
MyrbetriqMirabegron11$7,070
Advair HfaFluticasone Propion/Salmeterol13$5,613
Wixela InhubFluticasone Propion/Salmeterol19$3,861
Atorvastatin Calcium241$2,649
Losartan Potassium176$2,214
Rosuvastatin Calcium71$1,855
Mirtazapine44$1,693
Levothyroxine Sodium104$1,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$18$47,01046 claims
PfizerEliquis$58$32,80030 claims
Novo NordiskOzempic$72$32,23626 claims
MerckJanuvia$18$29,93620 claims
Boehringer IngelheimJardiance, Synjardy Xr$36$25,91325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 10,533 family medicine providers in California.

Other family medicine in Garden Grove

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →